- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
EUROPE & INDIA PHARMACEUTICAL SUMMIT | 13 October, 2015
The Summit was attended by Industry representatives (Italy & India), Drug Regulators across from European Continent & India (FDA). The government of India was represented by Commerce Secretary (Ministry of Commerce & Industry) and Jt. Secretary Mr Sudhanshu Pandey (Ministry of Commerce & Industry) –Pharmaceutical Industry. The summit was jointly coordinated by the Italy Pharmaceutical (Representation) Farmindustria & Pharmexcil (Pharma Export Council of India). Dr Gurpreet Sandhu conducted the summit as honorary advisor to Pharmexcil.